Clinical Biomedical Communications (CBC)

International, peer-reviewed, open-access journal.

Research Focus: Clinical Biomedical Communications (CBC) is dedicated to the rapid and efficient communication of clinically relevant biomedical knowledge. The journal aims to provide a fast, yet rigorous, editorial and peer-review pathway so that robust findings can move quickly from submission to publication and into clinical and translational use.

Open access publishing

No article processing charge (APC)

CBC promotes interdisciplinary research bridging basic molecular science and clinical medicine, enabling the translation of laboratory discoveries into improved patient care.

CBC focuses on rapid publication in translational biomedical research integrating molecular biology, clinical medicine, and emerging biomedical technologies in the following research areas:

• Translational medicine

• Molecular and cellular biology

• Clinical biochemistry

• Genomics and epigenetics

• Proteomics and metabolomics

• Microbiome research

• Molecular oncology

• Neurobiology

• Biomarker discovery

• Drug discovery and resistance

• Gene and cell therapy

• Precision medicine

• Immunology and vaccinology

The journal accepts several categories of manuscripts:

• Original Research Articles

• Mini-Review Articles

• Brief Case Reports

• Short Communications

• Methods and Protocols

• Letters to the Editor

This journal follows a single anonymized review process. Submissions are initially assessed by the editors to determine suitability for publication. If the submission is deemed suitable, it is typically sent to a minimum of two reviewers for an independent expert assessment of scientific quality.

All submitted manuscripts are reviewed by the journal editors. The editors reserve the right to reject without review those papers that do not meet the journal’s editorial criteria, either due to insufficient general interest or subject matter beyond the stated Aims & Scope of the journal.

Possible editorial decisions include:

• Accept

• Minor revision

• Major revision

• Reject

• Rigorous peer-review process

• Open access publishing

• No article processing charge (APC)

• Rapid editorial decision

• Global editorial board

• International authorship

CBC follows internationally recognized publication ethics guidelines from organizations such as:

• Committee on Publication Ethics (COPE)

• International Committee of Medical Journal Editors (ICMJE)

• World Association of Medical Editors (WAME)

Ethical requirements include:

• Original research only

• No plagiarism or duplicate publication

• Accurate reporting of data

• Proper citation of sources

• Ethical approval for human and animal research

All manuscripts are screened for originality via plagiarism-detection software to uphold the journal’s commitment to academic honesty and transparency across the global scientific community.

As a gold open-access journal, CBC utilizes the Creative Commons Attribution (CC BY) license, which empowers authors to retain copyright while facilitating the immediate, unrestricted sharing of their research.